BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for Feb. 4, 2020

Feb. 4, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Anavex, Biocryst, Glycomimetics.
Read More

Other news to note for Feb. 4, 2020

Feb. 4, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aevi Genomics, Anika, Anteros, Athenex, Arthrosurface, Beijing CC-Pharming, Biomotiv, Biosense Webster, BMS, Boehringer, Cerecor, Contrafect, Cormedix, CNS Pharmaceuticals, Equinox, Eyepoint, FSD, Genekam, Ibio, Inprother, Levena, Mablytics, Navrogen, Pattern Bioscience, Plex, Porton Pharma, Q Biomed, Rhythm AI, Salarius, Samus, Sirion, Solarvest, Syntrix, Theratechnologies, Trefoil, Trianni.
Read More

In the clinic for Feb. 4, 2020

Feb. 4, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkahest, Asklepios, Citius, Immix, IMV, Oncosec, Rebiotix, Zai.
Read More

Financings for Feb. 4, 2020

Feb. 4, 2020
Biopharmas raising money in public or private financings, including: Albireo, Arch Biopartners, Biontech, Black Diamond, Integra, Juvise, Kali-Extracts, Rockwell, Valneva.
Read More

Appointments and advancement for Feb. 4, 2020

Feb. 4, 2020
New hires and promotions in the biopharma industry, including: Catalyst, Freeline.
Read More

Other news to note for Feb. 3, 2020

Feb. 3, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ancora Heart, Avra Medical Robotics, Cypris Medica, Cvrx, Quest Diagnostics, Siemens Healthineers, Trimedx, Cybervista.
Read More

Appointments and advancements for Feb. 3, 2020

Feb. 3, 2020
New hires and promotions in the med-tech industry, including: Hhs, Lightship, Surmodics, Truvian Sciences.
Read More

Financings for Feb. 3, 2020

Feb. 3, 2020
Med-tech firms raising money in public or private financings, including: Ascyrus Medical, Lightship.
Read More

Regulatory actions for Feb. 3, 2020

Feb. 3, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Medalliance.
Read More

In the clinic for Feb. 3, 2020

Feb. 3, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lantheus, Oncosec.
Read More
Previous 1 2 … 1708 1709 1710 1711 1712 1713 1714 1715 1716 … 1808 1809 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing